statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Artelo Biosciences, Inc. (NASDAQ:ARTL - Free Report) - Research analysts at HC Wainwright decreased their FY2024 EPS estimates for shares of Artelo Biosciences in a research note issued on...

Brokers Offer Predictions for Artelo Biosciences, Inc.'s FY2024 Earnings (NASDAQ:ARTL)

Artelo Biosciences, Inc. (NASDAQ:ARTL - Free Report) - Equities researchers at HC Wainwright issued their Q1 2024 earnings per share estimates for shares of Artelo Biosciences in a report released on...

Artelo Biosciences, Inc. to Post Q1 2024 Earnings of ($1.05) Per Share, HC Wainwright Forecasts (NASDAQ:ARTL)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Artelo Biosciences reports 2023 EPS ($3.14), consensus ($2.56)

Major achievements in 2023 lay the foundation for key upcoming milestonesSOLANA BEACH, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage...

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update

Artelo Biosciences, Inc. (NASDAQ:ARTL  Get Free Report) was the target of a large growth in short interest in the month of February. As of February 29th, there was short interest totalling...

Artelo Biosciences, Inc. (NASDAQ:ARTL) Short Interest Up 117.6% in February

ART26.12 Preclinical Dermatology Research Presented to the Immuno-dermatology Leadership Team at Johnson & JohnsonSOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc...

Artelo Biosciences Selected as a Finalist in Johnson & Johnson's Innovation Challenge

SOLANA BEACH, CA / ACCESSWIRE / February 15, 2024 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th

SOLANA BEACH, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12's Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

SOLANA BEACH, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.

Watchers	10,083
52-Wk Low	$1.15
52-Wk High	$2.98

Volume	31,159.00
52-Wk High	$2.98
52-Wk Low	$1.15

ARTL Artelo Biosciences Inc

About

Feed

News

Fundamentals